Tag Archives: Odefsey

March, 2016

  • 2 March

    FDA Approves Gilead’s Single-Pill HIV Therapy Odefsey

    FOSTER CITY, Calif.–(BUSINESS WIRE)–Mar. 1, 2016– Gilead Sciences, Inc. (NASDAQ:GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Odefsey® (emtricitabine 200 mg/rilpivirine 25 mg/tenofovir alafenamide 25 mg or R/F/TAF) for the treatment of HIV-1 infection in certain patients. Emtricitabine and tenofovir alafenamide are from Gilead Sciences …